Mei Liu
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Hepatitis C virus research 4
-
- Liver Disease Diagnosis and Treatment 8
- Hepatitis B Virus Studies 4
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Glycosylation and Glycoproteins Research 4
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
-
- Gastrointestinal motility and disorders 3
- Co-authors
- Cong ZhangSujun ZhengZhongping DuanLin MaJing ZhangDan‐Dan BianXin ZhangYi Liu
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Mei Liu
37 papers receiving 351 citations
Peers
Comparison fields: 5 of 73
- Hepatology 90
- Epidemiology 123
- Endocrine and Autonomic Systems 16
- Immunology 50
- Radiology, Nuclear Medicine and Imaging 53
Countries citing papers authored by Mei Liu
This map shows the geographic impact of Mei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Liu more than expected).
Fields of papers citing papers by Mei Liu
This network shows the impact of papers produced by Mei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Liu. The network helps show where Mei Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mei Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2023 | 11 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 27 | |
| 10 | 2022 | 4 | |
| 11 | 2022 | 7 | |
| 12 | 2021 | 8 | |
| 13 | 2021 | 3 | |
| 14 | 2020 | 19 | |
| 15 | 2020 | 10 | |
| 16 | 2018 | 1 | |
| 17 | 2017 | 6 | |
| 18 | 2017 | 15 | |
| 19 | 2014 | 20 | |
| 20 | 2013 | 29 |
About Mei Liu
Mei Liu is a scholar working on Hepatology, Gastroenterology and Epidemiology, having authored 40 papers that have together received 358 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Glycosylation and Glycoproteins Research (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (4 papers) and Gastrointestinal motility and disorders (3 papers). The work is most often cited by research in Hepatology (90 citations), Epidemiology (123 citations) and Endocrine and Autonomic Systems (16 citations). Mei Liu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Cong Zhang, Sujun Zheng, Zhongping Duan, Lin Ma, Jing Zhang, Dan‐Dan Bian, Xin Zhang, Yi Liu, Xiru Li and Ailiang Zhang. Their work appears in journals such as Frontiers in Oncology, PeerJ, Tumor Biology, Journal of Agricultural and Food Chemistry and International Journal of Medical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.